Mountain Pacific Investment Advisers’s AbbVie ABBV Stock Holding History

Mountain Pacific Investment Advisers’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.34M	Sell	15,343 -250	-2%	-$55.5K	0.57%	45
2025 Q4	$3.56M	Sell	15,593 -50	-0.3%	-$11.4K	0.58%	44
2025 Q3	$3.62M	Sell	15,643 -664	-4%	-$135K	0.57%	42
2025 Q2	$3.03M	Sell	16,307 -1,201	-7%	-$223K	0.22%	57
2025 Q1	$3.67M	Sell	17,508 -100	-0.6%	-$19.4K	0.27%	53
2024 Q4	$3.13M	Hold	17,608	–	–	0.22%	55
2024 Q3	$3.48M	Buy	17,608 +900	+5%	+$168K	0.24%	54
2024 Q2	$2.87M	Sell	16,708 -706	-4%	-$117K	0.21%	54
2024 Q1	$3.17M	Sell	17,414 -300	-2%	-$51.7K	0.18%	58
2023 Q4	$2.75M	Sell	17,714 -150	-0.8%	-$21.9K	0.17%	63
2023 Q3	$2.66M	Sell	17,864 -274	-2%	-$40.2K	0.18%	61
2023 Q2	$2.44M	Sell	18,138 -300	-2%	-$44K	0.16%	64
2023 Q1	$2.94M	Sell	18,438 -900	-5%	-$138K	0.21%	62
2022 Q4	$3.13M	Sell	19,338 -286	-1%	-$43.9K	0.23%	60
2022 Q3	$2.63M	Sell	19,624 -369	-2%	-$53K	0.21%	60
2022 Q2	$3.06M	Sell	19,993 -762	-4%	-$116K	0.23%	59
2022 Q1	$3.37M	Sell	20,755 -170	-0.8%	-$24.7K	0.22%	58
2021 Q4	$2.83M	Sell	20,925 -1,500	-7%	-$177K	0.17%	60
2021 Q3	$2.42M	Sell	22,425 -693	-3%	-$79.2K	0.15%	61
2021 Q2	$2.6M	Sell	23,118 -731	-3%	-$82.3K	0.16%	61
2021 Q1	$2.58M	Sell	23,849 -71	-0.3%	-$7.59K	0.17%	60
2020 Q4	$2.56M	Sell	23,920 -163	-0.7%	-$15.7K	0.18%	60
2020 Q3	$2.11M	Buy	24,083 +569	+2%	+$53.6K	0.17%	58
2020 Q2	$2.31M	Sell	23,514 -107	-0.5%	-$9.42K	0.2%	58
2020 Q1	$1.8M	Buy	23,621 +820	+4%	+$69.8K	0.19%	60
2019 Q4	$2.02M	Hold	22,801	–	–	0.17%	59
2019 Q3	$1.73M	Hold	22,801	–	–	0.16%	60
2019 Q2	$1.66M	Buy	22,801 +386	+2%	+$30.3K	0.15%	60
2019 Q1	$1.81M	Sell	22,415 -300	-1%	-$24.5K	0.17%	56
2018 Q4	$2.09M	Sell	22,715 -325	-1%	-$28.6K	0.23%	49
2018 Q3	$2.18M	Hold	23,040	–	–	0.2%	50
2018 Q2	$2.13M	Hold	23,040	–	–	0.22%	49
2018 Q1	$2.18M	Hold	23,040	–	–	0.22%	47
2017 Q4	$2.23M	Sell	23,040 -150	-0.6%	-$14.1K	0.23%	51
2017 Q3	$2.06M	Hold	23,190	–	–	0.23%	51
2017 Q2	$1.68M	Sell	23,190 -750	-3%	-$50.4K	0.19%	55
2017 Q1	$1.56M	Sell	23,940 -4,090	-15%	-$257K	0.18%	56
2016 Q4	$1.75M	Sell	28,030 -245	-0.9%	-$15K	0.19%	54
2016 Q3	$1.78M	Sell	28,275 -420	-1%	-$27.2K	0.2%	55
2016 Q2	$1.78M	Sell	28,695 -400	-1%	-$24.4K	0.2%	53
2016 Q1	$1.66M	Sell	29,095 -3,050	-9%	-$170K	0.2%	54
2015 Q4	$1.9M	Sell	32,145 -7,200	-18%	-$415K	0.23%	55
2015 Q3	$2.14M	Hold	39,345	–	–	0.27%	54
2015 Q2	$2.64M	Sell	39,345 -447	-1%	-$29.2K	0.31%	52
2015 Q1	$2.33M	Sell	39,792 -100	-0.3%	-$6.04K	0.27%	54
2014 Q4	$2.61M	Hold	39,892	–	–	0.32%	52
2014 Q3	$2.3M	Sell	39,892 -1,200	-3%	-$66.6K	0.3%	54
2014 Q2	$2.32M	Sell	41,092 -200	-0.5%	-$10.5K	0.27%	56
2014 Q1	$2.12M	Sell	41,292 -200	-0.5%	-$10.1K	0.26%	55
2013 Q4	$2.19M	Buy	41,492 +745	+2%	+$36.6K	0.27%	54
2013 Q3	$1.82M	Hold	40,747	–	–	0.25%	55
2013 Q2	$1.68M	Buy	+40,747	New	+$1.78M	0.25%	55

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Mountain Pacific Investment Advisers's ABBV Position: Q1 2026 in Review

Mountain Pacific Investment Advisers reduced its AbbVie (ABBV) stake by 1.6% in Q1 2026, selling an estimated $55.5K and leaving 15,343 shares worth $3.34M. The position accounts for 0.57% of the portfolio, ranked #45.

Mountain Pacific Investment Advisers first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.67M in Q1 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Mountain Pacific Investment Advisers held 15,343 shares of AbbVie worth $3.34M as of Q1 2026.
Mountain Pacific Investment Advisers sold 250 AbbVie shares in Q1 2026, an estimated $55.5K.
AbbVie made up 0.57% of Mountain Pacific Investment Advisers's portfolio in Q1 2026, its #45 holding.
Mountain Pacific Investment Advisers first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
Mountain Pacific Investment Advisers's AbbVie position peaked at $3.67M in Q1 2025.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Mountain Pacific Investment Advisers's 13F filing for Q1 2026, filed 16 Apr 2026.